| 000 | 01690 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517025304.0 | ||
| 264 | 0 | _c20160407 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.05058-14 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDortet, Laurent | |
| 245 | 0 | 0 |
_aGenetic and biochemical characterization of OXA-405, an OXA-48-type extended-spectrum β-lactamase without significant carbapenemase activity. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cJul 2015 |
||
| 300 |
_a3823-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBacterial Proteins _xchemistry |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aCarbapenems _xtherapeutic use |
| 650 | 0 | 4 |
_aCephalosporins _xtherapeutic use |
| 650 | 0 | 4 |
_aDNA, Bacterial _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aPlasmids _xgenetics |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 650 | 0 | 4 |
_aSerratia Infections _xdrug therapy |
| 650 | 0 | 4 |
_aSerratia marcescens _xdrug effects |
| 650 | 0 | 4 |
_abeta-Lactamases _xchemistry |
| 700 | 1 | _aOueslati, Saoussen | |
| 700 | 1 | _aJeannot, Katy | |
| 700 | 1 | _aTandé, Didier | |
| 700 | 1 | _aNaas, Thierry | |
| 700 | 1 | _aNordmann, Patrice | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 59 _gno. 7 _gp. 3823-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.05058-14 _zAvailable from publisher's website |
| 999 |
_c24800940 _d24800940 |
||